Functional Analysis of a Unique Troponin C Mutation, GLY159ASP, that Causes Familial Dilated Cardiomyopathy, Studied in Explanted Heart Muscle
暂无分享,去创建一个
D. Ward | J. Kaski | Steven B Marston | J. Kentish | M. Burch | Clare E. Gallon | A. Messer | Anita C. Hoskins | Emma C. Dyer | Adam M. Jacques
[1] V. Tsang,et al. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. , 2008, Journal of molecular and cellular cardiology.
[2] H. Watkins,et al. The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy , 2008, Cardiovascular research.
[3] K. Clarke,et al. Investigation of a mouse model of familial DCM with ACTC E361G mutation , 2008 .
[4] W. Dong,et al. Structural Kinetics of Cardiac Troponin C Mutants Linked to Familial Hypertrophic and Dilated Cardiomyopathy in Troponin Complexes* , 2008, Journal of Biological Chemistry.
[5] Yves F Dufrêne,et al. High-resolution cell surface dynamics of germinating Aspergillus fumigatus conidia. , 2008, Biophysical journal.
[6] P. J. Griffiths,et al. Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and &agr;-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments , 2007, Circulation research.
[7] P. Elliott,et al. Mutations in the cardiac Troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood , 2007, Cardiology in the Young.
[8] W. Paulus,et al. Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies , 2007, Proteomics. Clinical applications.
[9] C. Redwood,et al. DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation. , 2007, Biochemical and biophysical research communications.
[10] Yuan-yuan Wang,et al. Knock-In Mouse Model of Dilated Cardiomyopathy Caused by Troponin Mutation , 2007, Circulation research.
[11] G. Boivin,et al. Dilated Cardiomyopathy Mutant Tropomyosin Mice Develop Cardiac Dysfunction With Significantly Decreased Fractional Shortening and Myofilament Calcium Sensitivity , 2007, Circulation research.
[12] P. D. de Tombe,et al. The Troponin C G159D Mutation Blunts Myofilament Desensitization Induced by Troponin I Ser23/24 Phosphorylation , 2007, Circulation research.
[13] H. Watkins,et al. The Effect of Mutations in α-Tropomyosin (E40K and E54K) That Cause Familial Dilated Cardiomyopathy on the Regulatory Mechanism of Cardiac Muscle Thin Filaments* , 2007, Journal of Biological Chemistry.
[14] H. Watkins,et al. Functional effects of the DCM mutant Gly159Asp Troponin C in skinned muscle fibres , 2007, Pflügers Archiv - European Journal of Physiology.
[15] M. Gautel,et al. Activation of Myocardial Contraction by the N-Terminal Domains of Myosin Binding Protein-C , 2006, Circulation research.
[16] J. Potter,et al. Functional Consequences of Hypertrophic and Dilated Cardiomyopathy-causing Mutations in α-Tropomyosin* , 2005, Journal of Biological Chemistry.
[17] J. Potter,et al. Sarcomeric Protein Mutations in Dilated Cardiomyopathy , 2005, Heart Failure Reviews.
[18] H. Watkins,et al. Dilated Cardiomyopathy Mutations in Three Thin Filament Regulatory Proteins Result in a Common Functional Phenotype* , 2005, Journal of Biological Chemistry.
[19] M. Antognozzi,et al. Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells. , 2005, American journal of physiology. Heart and circulatory physiology.
[20] H. Watkins,et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[21] K. Jaquet,et al. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways. , 2003, Journal of molecular and cellular cardiology.
[22] Steven R Houser,et al. Is depressed myocyte contractility centrally involved in heart failure? , 2003, Circulation research.
[23] H. Watkins,et al. Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy* , 2002, The Journal of Biological Chemistry.
[24] Steven B Marston,et al. In vitro motility analysis of thin filaments from failing and non-failing human heart: troponin from failing human hearts induces slower filament sliding and higher Ca(2+) sensitivity. , 2002, Journal of molecular and cellular cardiology.
[25] B. Brenner,et al. Mutation of the myosin converter domain alters cross-bridge elasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] K. Jaquet,et al. Effects of phosphorylation and mutation R145G on human cardiac troponin I function. , 2001, Biochemistry.
[27] C. Lim,et al. High-throughput assessment of calcium sensitivity in skinned cardiac myocytes. , 2001, American journal of physiology. Heart and circulatory physiology.
[28] D. Szczesna,et al. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. , 2001, The Journal of biological chemistry.
[29] S. Solomon,et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.
[30] N. Weissman,et al. Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy* , 2001, The Journal of Biological Chemistry.
[31] H. Watkins,et al. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. , 2000, Circulation research.
[32] M. Raida,et al. Variability in the ratio of mutant to wildtype myosin heavy chain present in the soleus muscle of patients with familial hypertrophic cardiomyopathy. A new approach for the quantification of mutant to wildtype protein , 1999, FEBS letters.
[33] Steven B Marston,et al. Functional analysis of human cardiac troponin by the in vitro motility assay: comparison of adult, foetal and failing hearts. , 1999, Cardiovascular research.
[34] C. Visser,et al. Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue. , 1998, Cardiovascular research.
[35] I. Fraser,et al. In Vitro Motility Analysis of Actin-Tropomyosin Regulation by Troponin and Calcium , 1995, The Journal of Biological Chemistry.
[36] F. Reinach,et al. Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. , 1994, The Journal of biological chemistry.
[37] Steven B Marston,et al. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. , 2007, Journal of molecular and cellular cardiology.
[38] Steven B Marston,et al. Cardiac and skeletal myopathies: can genotype explain phenotype? , 2004, Journal of Muscle Research & Cell Motility.
[39] Steven B Marston. Random walks with thin filaments: application of in vitro motility assay to the study of actomyosin regulation , 2004, Journal of Muscle Research & Cell Motility.
[40] Z. Papp,et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. , 2003, Cardiovascular research.